Program Book Update
(as of July 24, 2009)
Scientific Program
Thursday, July 30
9:00am-11:00am
F003 - New Technologies for ...
3:00pm-5:00pm
F012 - Case Based Controversies: Pediatric
Director: Karen Wiss, MD
Room: 313
• Ilona J. Frieden MD will be ...
• Andrea L. Zaenglein MD will be speaking.
• Jennie T. Clarke MD will be speaking.
• Emmy M. Graber MD will be speaking.
3...
• 11:20am – Hensin Tsao, MD, PhD Pigmented Lesions
• 11:40am – Neil Korman, MD, PhD Blistering Diseases
• 2:00pm – Bruce S...
4:45-5:00 Q&A
2:00pm-5:00pm
S015 - What's Boiling Over: Atopic Dermatitis & Other Eczematous Conditions
Director: Rod Sidb...
ADDITIONS
Thursday, July 30
• Council on Communications - Sheraton Boston - Gardner B, 3:30pm
• Council on Science and Res...
COMPANY NAME CHANGES
Former Company Name New Company Name Booth #
ADDITIONS
Company Name Booth #
Acupath Laboratories, Inc...
Upcoming SlideShare
Loading in...5
×

Councils/Committees/Task Forces

703

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
703
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Councils/Committees/Task Forces

  1. 1. Program Book Update (as of July 24, 2009) Scientific Program Thursday, July 30 9:00am-11:00am F003 - New Technologies for Minimally Invasive Skin Rejuvenation Director: Clay J. Cockerell, MD Room: 302 • Richard Rox Anderson MD will not be speaking. 9:00am-12:00pm S001 - What’s Hot: Women’s Dermatology Director: Boni E. Elewski, MD Room: Ballroom A Schedule Change: • 9:00am Boni E. Elewski, MD Introduction • 9:00am – 9:25am Amy McMichael, MD How to Approach Hair Loss In Women • 9:25am – 9:50am Mary Gail Mercurio, MD What A Dermatologist Needs To Know About Vulvar Disease • 9:50am – 10:15am Marian Northington, MD Filling In The Gaps • 10:15am – 10:40am Alexandra Boer Kimball, MPH Psoriasis In Women: Issues Unique To The Female Patient • 10:40am – 11:05am James Q. Del Rosso, DO Pearls in Management of Acne and Rosacea in Women • 11:05am – 11:30am Phoebe Rich, MD 5 Nail Tips Not to Gloss Over • 11:30am – 12:00pm Jeffrey P. Callen, MD Collagen Vascular Disease in Women 12:00pm-2:00pm F009 - Case Based Controversies: Dermatopathology Director: Jacqueline Junkins-Hopkins, MD Room: 310 • Antoinette Foote Hood MD will not be speaking. • Evan Ragland Farmer MD will not be speaking. • Clay J. Cockerell MD will be speaking. 12:00pm-2:00pm F011 - Case Based Controversies: Procedural Director: Desiree Ratner, MD Room: 313 • Deborah MacFarlane MD, MPH will not be speaking. • Fiona O'Reilly Zwald MD will be speaking. 2:00pm-5:00pm S005 - Essential Skills for NP/PA's in Dermatology Director: James Treat, MD Room: 304/306 • Albert Yan MD will be speaking. • Ellen Kim MD will be speaking. • Amit Garg MD will be speaking. • Christopher Miller MD will be speaking. • Robert Lee MD will be speaking. • Bethanee Schlosser MD will be speaking. 3:00pm-5:00pm W002 - Coding & Documentation Director: Daniel Siegel, MD Room: 202 • Allan S. Wirtzer MD will be speaking. • Mark Zalla MD will not be speaking. • James A. Zalla MD will be speaking. 1
  2. 2. 3:00pm-5:00pm F012 - Case Based Controversies: Pediatric Director: Karen Wiss, MD Room: 313 • Ilona J. Frieden MD will be speaking. • Hensin Tsao MD, PhD will be speaking. • Jane Margaret Grant-Kels MD will be speaking. • John B. Mulliken MD will be speaking. 3:00pm-5:00pm F013 - MOC Self-Assessment: Patient Safety Director: Hillary Johnson, MD Room: 203 • Susan Teri McGillis MD will be speaking. • Alice J. Watson MD will not be speaking. • Susan M. Swiggum, MD will not be speaking. Friday, July 31 12:00pm-2:00pm F015 - E-Prescribing Director: Jack Resneck Room: 208 • Marta Jane VanBeek MD will be speaking. 12:00pm-2:00pm F017 - Case Based Controversies: Medical Director: Mark D.P. Davis, MD Room: 310 • Rochelle R. Torgerson, MD, PhD will be speaking. 12:00pm-2:00pm F019 - Putting Your Best Hand Forward: The Anatomy, Pathology, and Difficulties of Surgical & Cosmetic Procedures On The Hands Director: Emily Fisher Room: 311 • Hugh M. Gloster Jr. MD will be speaking. • Ann G. Neff MD will be speaking. 2:00pm – 5:00pm S008 – Live Patient Demonstration: Botulinum toxin And Fillers Please note. Tuition fee and ticket required for admission. 2:00pm-5:00pm S006 - What’s Hot & What’s Not in Medical Dermatology Director: Joseph Jorizzo, MD Room: 304/306 Schedule Change: • 2:00pm – 2:15pm Jeff Callen, MD Overview of What’s Hot & What’s Not in Medical Dermatology • 2:15pm – 2:30pm Richard Granstein, MD Basic Science • 2:30pm – 2:45pm Andrew Lee, MD Dermatologic Emergencies • 2:45pm – 3:00pm Whitney High, MD Infectious Diseases • 3:00pm – 3:15pm Dan Pearce, MD Melanoma • 3:15pm – 3:30pm Joseph Jorizzo, MD Neutrophilic Vascular Reactions • 3:30pm – 3:45pm Manisha Patel, MD The Immunosuppressed Patient • 3:45pm – 4:00pm Gary Goldenberg , MD Dermatopathology Issues in Medical Dermatology • 4:00pm – 4:25pm David Cohen, MD Topical Therapy • 4:25pm – 4:50pm Alexa Kimball, MD Systemic Therapy • 4:50pm – 5:00pm Therapy – Questions & Answers 3:00pm-5:00pm F023 - MOCmd: Self-Assessment General Dermatology II Director: Bryan Erik Anderson, MD Room: 203 2
  3. 3. • Andrea L. Zaenglein MD will be speaking. • Jennie T. Clarke MD will be speaking. • Emmy M. Graber MD will be speaking. 3:00pm-5:00pm F024 - Is the Government a Partner in Your Practice? Director: Margaret Parsons, MD Room: 208 • Sandra I. Read MD will not be speaking. Saturday, August 1 9:00am-11:00am F027 - What's Hot & What's Not: Dermatopathology Director: Clay J. Cockerell, MD Room: 208 • Ashfaq A. Marghoob MD will not be speaking. • Peter F White MD will be speaking. 9:00am-11:00am F028 - Melanoma Director: Martin Weinstock, MD Room: 207 Updated session description: This session will address: (1) melanoma genetics for the dermatologist; (2) real progress in metastatic melanoma in 2009; (3) the new AJCC staging for cutaneous melanoma; (4) socioeconomic determinant of melanoma; and (5) the way forward for population-based early detection. 9:00am-5:00pm C002 - Dermatology Review Course – A Review of Dermatological Advancements Director: Jeffrey Callen, MD Room: 313 • Soon Bahrami MD will be speaking. • Susan Burgin MD will be speaking. • Jennie T. Clarke MD will be speaking. • Lisa M. Cohen MD will be speaking. • Jonathan A. Dyer MD will be speaking. • Lawrence F. Eichenfield MD will be speaking. • Dirk Michael Elston MD will be speaking. • Ilona J. Frieden MD will be speaking. • Mark Lebwohl MD will be speaking. • Frank C. Powell MD will be speaking. • Kathryn Schwarzenberger MD will be speaking. • Daniel M. Siegel MD will be speaking. • Bruce Elliot Strober MD, PhD will be speaking. • Hensin Tsao MD, PhD will be speaking. • Allison Therese Vidimos RPh, MD will be speaking. • Neil J. Korman MD, PhD will be speaking. • Ronald L. Moy MD will be speaking. • David Eric Cohen MD will be speaking. 9:00am-5:00pm C002 - Dermatology Review Course – A Review of Dermatological Advancements Director: Jeffrey Callen, MD Room: 313 Schedule Change: • 9:00am – Jeffrey P. Callen, MD Introduction • 9:01am – Ilona Frieden, MD Vascular lesions in children • 9:20am – Lisa Cohen, MD Dermatopathology – Inflammatory lesions • 9:40am – Jennie Clarke, MD Collagen-Vascular Disease • 10:00am – Mark Lebwohl, MD Psoriasis • 10:20am – Larry Eichenfield, MD Atopic Dermatitis • 10:40am – Alison Vidimos, RPh, MD Traditional Dermatologic Surgery • 11:00am – Susan Burgin, MD Drug-induced disease 3
  4. 4. • 11:20am – Hensin Tsao, MD, PhD Pigmented Lesions • 11:40am – Neil Korman, MD, PhD Blistering Diseases • 2:00pm – Bruce Strober, MD, PhD Systemic Therapies for Skin Disease • 2:20pm- Jon Dyer, MD Genodermatoses • 2:40pm- Kathryn Schwarzenberger, MD Skin Signs of Systemic Disease • 3:00pm- Soon Bahrami, MD Dermatopathology – Neoplasia • 3:20pm- David Cohen, MD Eczemas other than Atopic dermatitis • 3:40pm- Frank Powell, MD Acne and Rosacea • 4:00pm- Ron Moy, MD Aesthetic Surgery • 4:20pm- Daniel Siegel, MD Dermatological Informatics • 4:40pm- Dirk Elston, MD Patient Safety 2:00pm-5:00pm S012 – Cutting Edge: Surgery and Oncology Please note that a ticket is required for admission, no tuition fee. Ticket holds seat for only 15 minutes after the official start time for eligible attendees. 2:00pm-5:00pm S013 - Remote Patient Viewing Discussion: Beer and Wine Case Discussion Director: Susan Burgin, MD Room: 210 • Lily Changchien MD will be speaking. • Kristina M. Collins MD will be speaking. • Arash Mostaghimi MD will be speaking. • Haley Naik MD will be speaking. • Joshua Shofner MD will be speaking. • Ines Wu MD will be speaking. • Diana Castanon MD will be speaking. • Jordan M. Cummins MD will be speaking. • Anthony R. Cukras MD, PhD will be speaking. • Omar Ibrahimi MD, PhD will be speaking. • Adam D. Lipworth MD will be speaking. • Jennifer Tan-Billet MD will be speaking. • Falguni Asrani MD will be speaking. • Thanh-Nga Trinh Tran MD will be speaking. • Mohammed Sharaf MD will be speaking. • Jennifer Jenkins MD will be speaking. • Jessica Risser MD will be speaking. 2:00pm-5:00pm S014 - What's Breaking Out: Acne & Rosacea Director: Andrea Zaenglein MD Room: 304/306 • Lawrence F. Eichenfield MD will be speaking. 2:00-2:05 Introduction and Comments 2:05-2:30 Larry Eichenfield: Challenging Acne Cases 2:30-2:55 Bethanee Schlosser: Hormonal Therapies for Acne 2:55-3:20 Diane Thiboutot: Treatment of Rosacea 3:20-3:30 Q&A 3:30-3:55 Andrea Zaenglein: Acneiform Disorders in Childhood 3:55-4:20 Andrew Alexis: Treating Acne and Rosacea in Skin of Color 4:20-4:45 Emmy Graber: Laser Treatment of Acne Scarring 4
  5. 5. 4:45-5:00 Q&A 2:00pm-5:00pm S015 - What's Boiling Over: Atopic Dermatitis & Other Eczematous Conditions Director: Rod Sidbury, MD Room: Ballroom A • Lynda Schneider MD will be speaking. 2:00pm-5:00pm F030 – Tumor Board Director: Chrysalyne Delling Schmults MD Room: 208 • Chrysalyne Delling Schmults MD will not be speaking. • John A. Carucci, MD, PhD will be speaking. Room Changes Thursday, July 30, 9:00am to 11:00am C001 Practical Approaches to Patient Problems Room 206 Thursday, July 30, 3:00pm to 5:00pm F013 MOC Self-Assessment: Patient Safety Room 203 Thursday, July 30, 7:15am to 8:45am U002 Forensics in Dermatology Room 203 Thursday, July 30, 12:15pm to 1:45pm U010 Molecular Genetics of Melanoma Room 203 Thursday, July 30, 3:00pm to 5:00pm W003 Effictive Communictions in Your Community: Delivering Key Messages Room 303 Saturday, August 1, 9:00am to 5:00pm C002 Dermatology Review Course: A Review of Dermatological Advancements Room 302 Councils/Committees/Task Forces CANCELLATIONS Thursday, July 30 • Investment Committee - Clarendon A – Sheraton Boston, 9:00am • Excellence in Dermatology Endowment Fund - Berkley – Sheraton Boston, 12:00pm • Young Physician Committee - Hampton A – Sheraton Boston, 7:30am • Data Collection and Reporting Workgroup - Sheraton Boston - Clarendon B, 4:00pm • Workgroup on Health System Reform - Sheraton Boston – Gardner A, 9:00am Friday, July 31 • DAN/SkinPAC Reception - Back Bay Ballroom D – Sheraton Boston, 5:00pm • Health Care Finance Committee - Jefferson – Sheraton Boston, 7:00am • Ethics Committee -Berkeley A – Sheraton Boston, 12:00pm • Intersociety Liaison Committee – Gardner – Sheraton Boston, 2:00pm • Patient Safety Curriculum Workgroup - Sheraton Boston - Clarendon A, 2:00pm • Council on Member Services – Sheraton Boston – Berkeley B, 11:00am • Performance Measurement Task Force - Hampton B – Sheraton Boston, 2:00pm 5
  6. 6. ADDITIONS Thursday, July 30 • Council on Communications - Sheraton Boston - Gardner B, 3:30pm • Council on Science and Research - Sheraton Boston – Hampton B, 8:00am • Leadership Development Steering Committee - Sheraton Boston – Berkeley B, 5:00pm • Focus Group - Hynes Convention Center – Room 301, 10:30am • Focus Group - Hynes Convention Center – Room 301, 1:00pm Friday, July 31 • SkinPAC Board of Directors - Jefferson – Sheraton Boston, 2:00pm • Sr. Officer/AAD RUC Team Meeting - Jefferson – Sheraton Boston, 8:00am • Patient Safety & Quality Data Collection Workgroup - Hampton B – Sheraton Boston, 11:00am • Exhibitor Advisory Committee - Room 301 – Hynes Convention Center, 12:30pm CHANGES Thursday, July 30 • Former: Council on Government Affairs, Health Policy & Practice - Gardner B – Sheraton Boston, 12:00pm • New: Council on Government Affairs, Health Policy & Practice - Gardner B – Sheraton Boston, 8:30am Friday, July 31 • Former: Patient Safety and Quality - Hampton A – Sheraton Boston, 9:00am • New: Patient Safety and Quality - Clarendon – Sheraton Boston, 9:00am Ancillaries ADDITIONS Wednesday, July 29 • American Acne & Rosacea Society Board of Directors Meeting - Hampton A – Sheraton Boston, 12:00pm • National Psoriasis Foundation Medical Board Meeting - Hampton B – Sheraton Boston, 12:00pm Thursday, July 30 • WDS & WDSF Strategic Planning Meeting - Commonwealth – Sheraton Boston, 5:30pm Friday, July 31 • WDS Board Meeting - Commonwealth – Sheraton Boston, 6:30am • WDS Center - Conference Room 3 – Sheraton Boston, 8:00am • WDS Networking Reception - Top of the Hub, 5:30pm Saturday, August 1 • WDS Center - Conference Room 3 – Sheraton Boston, 8:00am • Skin & Aging Editorial Board Meeting - Berkeley 3 – Sheraton Boston, 7:00am Technical Exhibits BOOTH CHANGES Company Name From Booth # To Booth # Candela Corporation.....................................................201................................................................................322 CANCELLATIONS Company Name Booth # CleveX, Inc..........................................................................................................................................................618 Cosmedical Technologies, Inc............................................................................................................................917 Genentech...........................................................................................................................................................501 La Roche-Posay..................................................................................................................................................905 Vivacare..............................................................................................................................................................719 6
  7. 7. COMPANY NAME CHANGES Former Company Name New Company Name Booth # ADDITIONS Company Name Booth # Acupath Laboratories, Inc...................................................................................................................................905 Advanced Bio-Technologies, Inc.........................................................................................................................827 Anew Int..............................................................................................................................................................829 Basis Medical Technologies................................................................................................................................824 BigC.....................................................................................................................................................................520 Blinc Inc...............................................................................................................................................................719 Caris DX..............................................................................................................................................................723 Children’s Healthcare Research Group..............................................................................................................825 ChopSaver..........................................................................................................................................................522 Coria Laboratories...............................................................................................................................................305 Cosmetic Surgery Times/Dermatology Times.....................................................................................................211 Daavlin................................................................................................................................................................627 Dalo BioPharma..................................................................................................................................................917 Dermatology Foundation.....................................................................................................................................624 Doc2MD..............................................................................................................................................................823 Eisai.....................................................................................................................................................................923 Ellman International............................................................................................................................................826 Encite, Inc...........................................................................................................................................................922 Fallene LTD.........................................................................................................................................................623 Fujiiryoki/AC1G1.................................................................................................................................................209 Hoya ConBio.......................................................................................................................................................924 IntrOp Mecial.......................................................................................................................................................224 Kaiser Permanente.............................................................................................................................................622 Lippincott Wiliams & Wilkins...............................................................................................................................201 Lucid, Inc.............................................................................................................................................................219 Lumenis...............................................................................................................................................................424 Market Foresight.................................................................................................................................................926 MDLand International..........................................................................................................................................521 MEDART-FX.......................................................................................................................................................225 Medesthetics Magazine......................................................................................................................................919 Mentor Corporation.............................................................................................................................................725 Michelson Diagnostics LTD.................................................................................................................................221 Quality of Life......................................................................................................................................................921 Osyris Medical USA............................................................................................................................................325 Palomar Medical Technologies, Inc....................................................................................................................822 PathLogix Corporation........................................................................................................................................920 Person & Covey..................................................................................................................................................621 Pharmaceutical Specialties, Inc..........................................................................................................................423 Primus Pharmaceuticals, Inc...............................................................................................................................222 Promius Pharma.................................................................................................................................................708 Quality Life, The..................................................................................................................................................921 Ruferd Corporation..............................................................................................................................................925 Senetek PLC.......................................................................................................................................................204 Sesderma Laboratories.......................................................................................................................................501 Skin & Cancer Associates/Advanced Dermatology Management......................................................................220 Skin Cancer Foundation, The.............................................................................................................................223 Syneron...............................................................................................................................................................625 UVSunsense, LLC...............................................................................................................................................208 Warner Chilcott (US), LLC..................................................................................................................................422 7

×